Naturally Splendid Enterprises Ltd. (“Naturally Splendid” or “NSE” or “The Company”) (TSXV:NSP) (OTCQB:NSPDF) (Frankfurt:50N) is pleased to announce it has received a purchase order from Pure Integrative Pharmacy for NATERAFX™.
NATERA FX™ will now be available at all 15 Pure Integrative Pharmacy locations; 14 in Greater Vancouver and one in Courtenay, B.C.
Dr. Swetlikoff, Lead Medical Advisor for NATERA FX™ and Advisory Board Member of Naturally Splendid states, “We are pleased to have secured our first pharmacy chain as clients of NATERA FX™. Although many practitioners carry an inventory of products for clients, there are also those who choose not to and refer their patients to pharmacies. In this regard, Pure Integrative Pharmacies will serve as a dispensary for NATERA FX products. Furthermore, pharmacists that have access to NATERA FX™ will also be able to recommend the products directly to their customers. We look forward to adding additional pharmacy chains to provide wide access to NATERA FX™ products”.
NATERA FX™ products are marketed directly to health care professionals, including but not limited to, Naturopathic Doctors, Doctors of Chiropractic, Medical Doctors and Pharmacies via a nationwide network of Medical Advisors and Consultants as well as an e-Commerce website.
Additional Natural Product Numbers (NPNs):
NATERA FX™ currently has five products that have received Natural Product Numbers (NPNs) from Health Canada. They are as follows:
- LEAN FX Body Composition Formula (619g) NPN: 80087708
- MATRIX Bone & Joint Formula (90C) NPN: 80089215
- MVP Multivitamin & Phytonutrient Formula (120C) NPN: 80085246
- PHYTO MOOD Mood Imbalance & Sleep Aid (90C) NPN: 80084609
- RELIEF Anti-Inflammatory Formula (60C) NPN: 80082780
Appointed to the NATERA FX Medical Team as Medical Consultant
Dr. Laura Stix, BSc (Hons) ND
Dr. Stix is a licensed Naturopathic Doctor (Boucher Institute of Naturopathic Medicine, New Westminster, BC) with an Honours Degree in Science from the University of Waterloo, ON, graduating magna cum laude with a Major in Psychology and a Minor in Biology. Awarded a research grant to study the brain, her interests ultimately led to mind-body medicine, completing advanced training in hypnotherapy and neuro-linguistic programming.
Dr. Stix practices in Waterloo, ON, and has joined the NATERA FX™ team as a Medical Consultant to health care professionals in Ontario where she directly consults with multiple disciplines – including Naturopathic Doctors, Doctors of Chiropractic, Medical Doctors, Pharmacists, and others – to guide them in recommending the most effective application of the NATERAFX™ professional line of natural health products for their clients. With a decade of clinical experience, her practice is centered on lifestyle medicine and evidence-based therapies.
For more information on NATERA FX™, please visit their website: www.naterafx.com
About Naturally Splendid Enterprises Ltd.
Naturally Splendid is a biotechnology and consumer products company that is developing, producing, commercializing, and licensing an entirely new generation of plant-derived, bioactive ingredients, nutrient dense foods, and related products. Naturally Splendid is building an expanding portfolio of patents (issued and pending) and proprietary intellectual property focused on the commercial uses of industrial hemp cannabinoid compounds in a broad spectrum of applications.
For more information e-mail firstname.lastname@example.org or call Investor Relations at 604-673-9573
On Behalf of the Board of Directors
Mr. Douglas Mason
Naturally Splendid Enterprises Ltd.
(NSP – TSX Venture; NSPDF – OTCQB; 50N Frankfurt)
#108-19100 Airport Way
Pitt Meadows, BC, V3Y 0E2
Office: (604) 465-0548
Fax: (604) 465-1128
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid’s control including, Naturally Splendid’s ability to compete with large food and beverage companies; sales of any potential products developed will be profitable; sales of shelled hemp seed will continue at existing rates or increase; the ability to complete the sales of all bulk hemp seed purchase orders; and the risk that any of the potential applications may not receive all required regulatory or legal approval. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information.
NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
In the evolving rush of mergers and acquisitions (M&A) in the Canadian cannabis market, Canopy Growth (NASDAQ:CGC,TSX:WEED) announced it will acquire The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF) in a deal worth approximately C$435 million.
Meanwhile, a cannabis operator in the US confirmed this week that it will receive a financial boost from a partner to solidify its position in the burgeoning Pennsylvania state market.
The Board of Directors of Aphria Unanimously Recommends Shareholders Vote “For” the Arrangement
Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination
Love Hemp Group PLC (AQSE: LIFE) (OTCQB: WRHLF), one of the UK’s leading CBD and Hemp product suppliers, announces that as part of the equity fundraise announced yesterday, Antony Calamita and Andrew Male, Directors of the Company, subscribed for 285,714 Ordinary Shares and 1,428,571 Ordinary Shares respectively. The subscriptions are at a price of 3.5 pence per ordinary share for a total of £60,000. Following these subscriptions, Antony Calamita is now interested in 54,385,714 Ordinary Shares, representing 8.61% of the Company’s share capital as increased by the fundraising, and Andrew Male is now interested in 6,138,196 Ordinary Shares, representing 0.97% of the Company’s issued share capital as increased by the fundraising
Further, the timetable for receipt of applications under the Broker Option, which was also announced yesterday, has been extended until 5:00 pm 9 April 2021 to capture additional interest which was unable to be completed yesterday.
Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, would like to provide the following dial-in information for the Company’s upcoming Annual and Special Meeting (the “Meeting”) scheduled to be held at 11:00 a.m. Eastern Daylight Time on April 12, 2021. Shareholders and proxyholders may access the Meeting via teleconference by dialing 647-723-3984 or 1-866-365-4406 from Canada or the United States, then entering participation code “8487744” followed by the pound (“#”) sign.
In consideration of the COVID-19 pandemic and the recent restrictions imposed by the Ontario Provincial Government, shareholders and proxyholders will only be able to attend the Meeting via teleconference and will not be permitted to attend the Meeting in person at the address provided on the Notice of Annual and Special Meeting of Shareholders.
Gage Cannabis Announces Exclusive Partnership With Blue River to Bring Award-Winning Cannabis Extracts to Michigan
Gage Growth Corp. (“Gage” or the “Company”) (CSE:GAGE), a leading high-quality craft cannabis brand and operator in Michigan, announced today that it has signed an agreement with Blue River™ Extracts & Terpenes (“Blue River™”) to bring the brand’s award-winning solventless technology and other trademark branded products to the state’s medical patients and cannabis consumers. The Company will have exclusive rights to Blue River™’s premium product offerings in Michigan.